ATE121739T1 - Discodermolideverbindungen, diese enthaltende zubereitungen, verfahren zu ihrer herstellung und deren verwendung. - Google Patents

Discodermolideverbindungen, diese enthaltende zubereitungen, verfahren zu ihrer herstellung und deren verwendung.

Info

Publication number
ATE121739T1
ATE121739T1 AT90912243T AT90912243T ATE121739T1 AT E121739 T1 ATE121739 T1 AT E121739T1 AT 90912243 T AT90912243 T AT 90912243T AT 90912243 T AT90912243 T AT 90912243T AT E121739 T1 ATE121739 T1 AT E121739T1
Authority
AT
Austria
Prior art keywords
compounds
production
preparations containing
coz
coa
Prior art date
Application number
AT90912243T
Other languages
English (en)
Inventor
Malika Gunasekera
Sarath P Gunasekera
Ross E Longley
Neal Burres
Original Assignee
Harbor Branch Oceanographic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harbor Branch Oceanographic filed Critical Harbor Branch Oceanographic
Application granted granted Critical
Publication of ATE121739T1 publication Critical patent/ATE121739T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
AT90912243T 1989-08-11 1990-08-09 Discodermolideverbindungen, diese enthaltende zubereitungen, verfahren zu ihrer herstellung und deren verwendung. ATE121739T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/392,468 US4939168A (en) 1989-08-11 1989-08-11 Discodermolide compounds, compositions containing same and methods of preparation and use

Publications (1)

Publication Number Publication Date
ATE121739T1 true ATE121739T1 (de) 1995-05-15

Family

ID=23550726

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90912243T ATE121739T1 (de) 1989-08-11 1990-08-09 Discodermolideverbindungen, diese enthaltende zubereitungen, verfahren zu ihrer herstellung und deren verwendung.

Country Status (9)

Country Link
US (1) US4939168A (de)
EP (1) EP0486565B1 (de)
JP (1) JP3008985B2 (de)
AT (1) ATE121739T1 (de)
CA (1) CA2056412C (de)
DE (1) DE69018991T2 (de)
DK (1) DK0486565T3 (de)
ES (1) ES2071826T3 (de)
WO (1) WO1991001982A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE314845T1 (de) 1993-07-29 2006-02-15 Us Health Verwendung von paclitaxel und seinen derivaten zur herstellung eines medikaments für die behandlung von restenose
GB9315802D0 (en) * 1993-07-30 1993-09-15 Roussel Lab Ltd Chemical compounds
US5478861A (en) * 1994-02-18 1995-12-26 Harbor Branch Oceanographic Institution, Inc. Cytotoxic macrolides and methods of use
US5684036A (en) * 1994-02-18 1997-11-04 Harbor Branch Oceanographic Institution, Inc. Cytotoxic macrolides and methods of use
US5681847A (en) * 1995-12-05 1997-10-28 Harbor Branch Oceanographic Institution, Inc. Methods of using discodermolide compounds
US5789605A (en) * 1996-12-03 1998-08-04 Trustees Of The University Of Pennsylvania Synthetic techniques and intermediates for polyhydroxy, dienyl lactones and mimics thereof
US20050065353A1 (en) * 1996-12-03 2005-03-24 Smith Amos B. Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
US6127406A (en) * 1998-10-09 2000-10-03 Harbor Branch Oceanographic Institution, Inc. Discodermolide compounds and methods of use
US6384187B1 (en) 1999-05-15 2002-05-07 Harbor Branch Oceanographic Institution, Inc. Antiproliferative activity of microsclerodermins
AU2001247241A1 (en) 2000-03-01 2001-09-12 Harbor Branch Oceanographic Institution, Inc. Biologically active analogs of discodermolide
MY127609A (en) * 2000-08-07 2006-12-29 Novartis Ag Process for preparing discodermolide and analogues thereof
US6541509B2 (en) 2000-09-15 2003-04-01 Albert Einstein College Of Medicine Of Yeshiva University Method for treating neoplasia using combination chemotherapy
US6734177B2 (en) * 2001-04-17 2004-05-11 Novartis Ag Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors
CN100522956C (zh) * 2001-08-06 2009-08-05 诺瓦提斯公司 取代的聚酮化合物,包含它们的药物组合物及其在治疗肿瘤中的用途
TW200408407A (en) * 2001-11-30 2004-06-01 Dana Farber Cancer Inst Inc Methods and compositions for modulating the immune system and uses thereof
AU2003226717A1 (en) * 2002-03-27 2003-10-08 Novartis Ag Intermediates for the synthesis of discodermolide and related analogues and methods for their preparation
WO2005084349A2 (en) * 2004-03-02 2005-09-15 Kosan Biosciences, Inc. Compounds useful for the synthesis of (+)-discodermolide and methods therefor
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
US7214708B2 (en) * 2004-11-18 2007-05-08 Kosan Biosciences Incorporated Synthetic discodermolide analogs
JP4954983B2 (ja) 2005-05-18 2012-06-20 ファーマサイエンス・インコーポレイテッド Ｂｉｒドメイン結合化合物
BRPI0711385A2 (pt) 2006-05-09 2011-11-08 Novartis Ag combinação compreendendo um quelante de ferro e um agente anti-neoplástico e seu uso
EP2024362A4 (de) 2006-05-16 2012-01-25 Pharmascience Inc An die iap-bir-domäne bindende verbindungen
WO2009049378A1 (en) * 2007-10-17 2009-04-23 Qbiotics Limited Lactone derivatives
RS56741B1 (sr) 2009-11-13 2018-03-30 Daiichi Sankyo Europe Gmbh Materijal i postupci za lečenje ili prevenciju bolesti povezanih sa her-3
US9284350B2 (en) 2010-02-12 2016-03-15 Pharmascience Inc. IAP BIR domain binding compounds
AU2011286407A1 (en) 2010-08-06 2013-02-21 Amgen Use of HER3 binding agents in prostate treatment

Also Published As

Publication number Publication date
DE69018991T2 (de) 1995-08-24
JPH04507245A (ja) 1992-12-17
US4939168A (en) 1990-07-03
EP0486565A1 (de) 1992-05-27
DE69018991D1 (de) 1995-06-01
CA2056412A1 (en) 1991-02-12
DK0486565T3 (da) 1995-10-02
CA2056412C (en) 2001-04-10
WO1991001982A1 (en) 1991-02-21
ES2071826T3 (es) 1995-07-01
EP0486565B1 (de) 1995-04-26
JP3008985B2 (ja) 2000-02-14

Similar Documents

Publication Publication Date Title
ATE121739T1 (de) Discodermolideverbindungen, diese enthaltende zubereitungen, verfahren zu ihrer herstellung und deren verwendung.
FI954898A0 (fi) Vesiliukoiset kamptotesiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö kasvaintenvastaisina aineina
IL57577A (en) 1,2-dihydroquinolin-2-one derivatives,processes for their preparation and pharmaceutical compositions containing the same
ATE16805T1 (de) Trifluoromethylphenyltetrahydropyridine mit appetithemmender wirkung, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
SE8405754D0 (sv) 7-karboximetoxi-furo-(3,4-c)-pyridinderivat, framstellning derav och terapeutiska kompositioner innehallande dem
FI933903A0 (fi) Substituerade cyklohexanderivat, foerfarande foer framstaellning daerav och anvaendning av foereningar foer behandling av sjukdomar
ES2064461T3 (es) Derivados de xantina, procedimiento para su preparacion y composicion farmaceutica.
DE3670081D1 (de) Imidazolderivate, verfahren zu deren herstellung, deren anwendung und pharmazeutische zusammenstellungen.
PT78062B (fr) Procede pour preparer de nouveaux derives de betaines n-iminopyridinium et de compositions pharmaceutiques les contenant
ATE42279T1 (de) Guanidinobenzoesaeureesterderivate, ein verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE59637T1 (de) Neue basisch substituierte pyridinverbindungen, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung.
ATE34739T1 (de) Neue 2-pyridin-thiol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DE59309812D1 (de) Asymmetrische Hydrierung
SE9203824L (sv) Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
HUT42099A (en) Process for preparing 2,3-diamino-2,3-dideoxy-hexose derivatives and pharmaceutical compositions containing thereof as active substances
PT77683A (de) Neue benzazepinderivate ihre herstellung und ihre verwendung als arzneimittel
SE8903313L (sv) Nya 2-metoxikarbonyl-substituerade n,n'-di-(trimetoxibensoyl)-piperaziner, foerfarande foer framstaellning daerav och terapeutiska foereningar innehaallande dem
NZ237684A (en) Flavone derivatives, medicaments, and precursors
ATE49207T1 (de) 3-iminopyridazinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
FR2655042B1 (fr) Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE145647T1 (de) Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen
IT1237506B (it) Derivati amminici di 2,3-diaza-antracene-9,10-dioni come farmaci antitumorali
GEP20022796B (en) Novel Aryloxy-Alkyl-Dialkylamines

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time